Personal information

No personal information available

Activities

Employment (5)

Washington University in St Louis: St Louis, MO, US

2022-10-01 to present | Assistant Professor (Pathology and Immunology)
Employment
Source: Self-asserted source
umang jain

Washington University in St. Louis: St Louis, Missouri, US

2020-02-10 to 2022-09-30 | Instructor (Pathology and Immunology)
Employment
Source: Self-asserted source
umang jain

Washington University in St. Louis: St Louis, Missouri, US

2019-02-05 to 2020-01-15 | Scientist (Pathology and Immunology)
Employment
Source: Self-asserted source
umang jain

Washington University in Saint Louis/: Saint Louis, MO, US

2015-11-15 to 2019-02-03 | Postdoctoral research fellow (Pathology)
Employment
Source: Self-asserted source
umang jain

Biocon Bristol-Myers Squibb Research and Development Center: Bangalore, Karnataka, IN

2009-08-12 to 2010-08-13 | Research Associate-II (Biology)
Employment
Source: Self-asserted source
umang jain

Education and qualifications (3)

Dalhousie University Faculty of Medicine: Halifax, NS, CA

2010-09-04 to 2015-08-30 | PhD (Microbiology and Immunology)
Education
Source: Self-asserted source
umang jain

Manipal University: Manipal, Karnataka, IN

2007-09-08 to 2009-07-30 | MSc Medical biotechnology (School of Life Sciences)
Education
Source: Self-asserted source
umang jain

Manipal University: Manipal, Karnataka, IN

2004-08-15 to 2007-06-30 | BSc Biotechnology (school of life sciecnes)
Education
Source: Self-asserted source
umang jain

Funding (6)

Inflamed tissue associated fungi and mucosal healing in Inflammatory bowel diseases

2020-04 to present | Grant
Boehringer Ingelheim (CT, CT, US)
Source: Self-asserted source
umang jain

Mesenchymal stem cells and epithelial repair

2015-11 to 2018-11 | Salary award
Washington University in St. Louis (MO, MO, US)
Source: Self-asserted source
umang jain

Travel award to Nature symposium,2014

2014-11 to 2014-11 | Award
Beatrice Hunter Cancer Research Institute (NS, NS, CA)
Source: Self-asserted source
umang jain

Role of complement in inflammatory bowel disease

2014-01 to 2015-08 | Award
IWK health centre graduate scholarship (halifax, halifax, CA)
Source: Self-asserted source
umang jain

Role of complement in chemotherapy induced mucositis

2013-01 to 2013-12 | Award
Beatrice Hunter Cancer Research Institute (NS, NS, CA)
Source: Self-asserted source
umang jain

Conference grant for ICMI 2011

Award
IWK conference presentation award (halifax, CA)
Source: Self-asserted source
umang jain

Works (13)

NAD + precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunction

Science Translational Medicine
2024-01-03 | Journal article
Contributors: Atika Malique; Shengxiang Sun; Kanta Chandwe; Beatrice Amadi; Talin Haritunians; Umang Jain; Brian D. Muegge; Jennifer Frein; Yo Sasaki; Amanda Foster et al.
Source: check_circle
Crossref

Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice

Science
2021-03-12 | Journal article
Contributors: Umang Jain; Aaron M. Ver Heul; Shanshan Xiong; Martin H. Gregory; Elora G. Demers; Justin T. Kern; Chin-Wen Lai; Brian D. Muegge; Derek A. G. Barisas; J. Steven Leal-Ekman et al.
Source: check_circle
Crossref

PAI-1 augments mucosal damage in colitis

Science Translational Medicine
2019-03-06 | Journal article
Part of ISSN: 1946-6234
Part of ISSN: 1946-6242
Source: Self-asserted source
umang jain

Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration.

Cell host & microbe
2018-08 | Journal article
Contributors: Jain U; Lai CW; Xiong S; Goodwin VM; Lu Q; Muegge BD; Christophi GP; VanDussen KL; Cummings BP; Young E et al.
Source: Self-asserted source
umang jain via Europe PubMed Central

Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.

Molecular microbiology
2018-03 | Journal article
Contributors: Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM et al.
Source: Self-asserted source
umang jain via Europe PubMed Central

The microbial metabolite desaminotyrosine protects from influenza through type I interferon.

Science (New York, N.Y.)
2017-08 | Journal article
Contributors: Steed AL; Christophi GP; Kaiko GE; Sun L; Goodwin VM; Jain U; Esaulova E; Artyomov MN; Morales DJ; Holtzman MJ et al.
Source: Self-asserted source
umang jain via Europe PubMed Central

Erdheim-Chester Disease presenting with histiocytic colitis and cytokine storm.

Journal of gastrointestinal and liver diseases : JGLD
2017-06 | Journal article
Contributors: Christophi GP; Sharma Y; Farhan Q; Jain U; Walker T; Sayuk GS; Rubin DC
Source: Self-asserted source
umang jain via Europe PubMed Central

Properdin deficiency protects from 5-fluorouracil-induced small intestinal mucositis in a complement activation-independent, interleukin-10-dependent mechanism.

2017-04 | Journal article
Contributors: Jain U; Midgen CA; Woodruff TM; Schwaeble WJ; Stover CM; Stadnyk AW
Source: Self-asserted source
umang jain via Europe PubMed Central

Do antimicrobial peptides and complement collaborate in the intestinal mucosa?

2015 | Journal article
Contributors: Kopp ZA; Jain U; Van Limbergen J; Stadnyk AW
Source: Self-asserted source
umang jain via Europe PubMed Central

Properdin Regulation of Complement Activation Affects Colitis in Interleukin 10 Gene-Deficient Mice.

2015-07 | Journal article
Contributors: Jain U; Midgen CA; Schwaeble WJ; Stover CM; Stadnyk AW
Source: Self-asserted source
umang jain via Europe PubMed Central

Properdin provides protection from Citrobacter rodentium-induced intestinal inflammation in a C5a/IL-6-dependent manner.

2015-04 | Journal article
Contributors: Jain U; Cao Q; Thomas NA; Woodruff TM; Schwaeble WJ; Stover CM; Stadnyk AW
Source: Self-asserted source
umang jain via Europe PubMed Central

The complement system in inflammatory bowel disease.

2014-09 | Journal article
Contributors: Jain U; Otley AR; Van Limbergen J; Stadnyk AW
Source: Self-asserted source
umang jain via Europe PubMed Central

The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10.

2013-01 | Journal article
Contributors: Jain U; Woodruff TM; Stadnyk AW
Source: Self-asserted source
umang jain via Europe PubMed Central